Clinical Trial Update: Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients [NA]

View source ↗

Summary

This clinical trial update reports on berberine used as an adjunctive therapy to schizophrenia, assessing effects on cytokines, CRP, and metabolic disturbances.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: Tianjin Anding Hospital | Conditions: Schizophrenia | NA | Status: COMPLETED